Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EPCAM divergent transcript (EPCAM-DT) is a long non-coding RNA (lncRNA) gene located on chromosome 2 (chr2:47192405–47345112, hg38)[1][5]. It is classified as a non-protein coding RNA gene and is not known to encode a functional protein or receptor[5]. The gene is listed with the identifier LOC107985882 in NCBI gene databases, and its main known feature is its classification as a divergent transcript relative to EPCAM, meaning it is transcribed in the direction opposite to the protein-coding EPCAM gene[1][5]. There is no current evidence to suggest EPCAM-DT is a therapeutic target, nor are there details on its biological function, disease involvement, or interactions with drugs. Further research may be necessary to clarify any functional roles, but as of now, it is primarily considered a lncRNA with unknown function in human biology[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EPCAM divergent transcript (EPCAM-DT).